About Us
GENPROTIC Biopharma (GB) Pvt. Ltd, founded in January 2020 in Chennai, India, is a pioneering venture dedicated to advancing healthcare through innovative biosimilar drugs. With a strong emphasis on molecular and genetic engineering, GB leverages cutting-edge technology to develop a diverse range of products aimed at addressing critical medical needs.
GB boasts a team of highly skilled experts proficient in various aspects of biopharmaceutical development, including cloning, protein expression, upstream and downstream processes, and analytical characterization. The company's robust infrastructure includes state-of-the-art molecular biology, upstream, downstream, and analytical laboratories, facilitating comprehensive research and development capabilities.
Mission
At Genprotic biopharma, our mission is to harness the power of advanced technology and scientific expertise to develop next-generation biosimilar drugs and molecular diagnostic solutions. We are committed to addressing pressing medical challenges.
Vision
To lead the forefront of biopharmaceutical innovation, utilizing cutting-edge molecular diagnostics and genetic engineering to revolutionize global healthcare delivery.
Dr. P. Suthakaran, Founder and Managing Director
Dr. P. Suthakaran is an accomplished biotechnologist with over 23 years of expertise in biotechnology research, recombinant protein technology, and bioprocess development. He holds an M.Tech in Biotechnology and a Ph.D. in Genetic Engineering from Anna University, India.
His core expertise encompasses recombinant protein expression, molecular cloning, strain engineering, fermentation, and downstream processing. He specializes in developing and optimizing high-yield microbial and mammalian expression systems for recombinant proteins.
His technical experience includes E. coli and yeast-based expression platforms, protein folding, solubility enhancement, and process optimization. Dr. Suthakaran has contributed to the development of recombinant therapeutic proteins, diagnostic antigens, antibodies, recombinant enzymes and clinical enzymes, and other high-value biopharmaceutical molecules.
Prior to founding Genprotic Biopharma, he served as a Senior Scientist at Anthem Biosciences Pvt. Ltd., Bangalore. He also worked as a Post-Doctoral Research Fellow in China, gaining advanced exposure to protein engineering and biotechnology research. Dr. Suthakaran focuses on translating laboratory-scale discoveries into robust, scalable, and commercially viable bioprocesses.
At Genprotic Biopharma, he leads R&D, technology development, process scale-up, and strategic innovation in recombinant biotechnology. His vision is to establish advanced recombinant protein and bio-processing technologies for global diagnostic, therapeutic, and industrial biotechnology applications.